• 1
    Allergen immunotherapy: therapeutical vaccines for allergic diseases BousquetJ, LockeyRF, MallingH-J WHO position paperEuropean Journal of Allergy and Clinical Immunology, 1998;53 Suppl 44:1 12
  • 2
    EAACI position paper on allergen immunotherapyMallingH-J, WeekeBEuropean Journal of Allergy and Clinical Immunology, 1993;48 Suppl 14:9 35
  • 3
    British Society of Allergy and Clinical ImmunologyPosition paper on allergen immunotherapy. Clin Exp Allergy 1993;23:3 14
  • 4
    Abramson MJ, Puy RM, Weiner JM. Is allergen specific immunotherapy effective in asthma?. Am J Respir Crit Care Med 1995;151:969 974
  • 5
    Norman PS. WHO-IUIS International Standards. Advantages of these extracts. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 1994;87:59 64
  • 6
    Passalacqua G & Canonica GW. Alternative routes for immunotherapy. J Invest Allergol Clin Immunol 1996;6:81 86
  • 7
    Grammer LC, Shaughnessy MA, Patterson R. Modified forms of allergen immunotherapy. J Allergy Clin Immunol 1985;76:397 401
  • 8
    Marsh DG, Norman PS, Roebber M, Lichtenstein LM. Studies of allergoids from naturally occurring allergens. III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps. J Allergy Clin Immunol 1981;68:449 459
  • 9
    Bousquet J, Heijaoui A, Soussana M, Michel FB. Double blind placebo controlled immunotherapy with mixed grass pollen allergoids. IV. Comparison of the efficacy and safety of two dosages of a high molecular weight allergoid. J Allergy Clin Immunol 1990;85:490 497
  • 10
    Pastorello EA, Pravettoni V, Incorvaia C, Ortolani C. Clinical and immunological effects of immunotherapy with alum absorbed grass allergoid in grass pollen induced hay fever. Allergy 1992;47:281 290
  • 11
    Meriney DK, Kothari H, Chinoy P, Grieco MH. The clinical and immunological efficacy of immunotherapy with modified ragweed extract (allergoid) for ragweed hay fever. Ann Allergy 1986;56:34 38
  • 12
    Grammer LC, Shaughnessy SA, Suszko IM, Shaughnessy JJ, Patterson R. Persistence of efficacy after a brief course of polymerized ragweed allergen: a controlled study. J Allergy Clin Immunol 1984;73:484 489
  • 13
    Hedlin G, Heilborn H, Liljia G, Løwenstein H. Long-term follow up of patients treated with a three-year course of cat or dog immunotherapy. J Allergy Clin Immunol 1995;96:879 885
  • 14
    Jacobsen L, Nüchel-Petersen B, Wihl JÅ, Løwenstein H, Ipsen H. Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow-up. Allergy 1997;52:914 920
  • 15
    Jones LA, Jones RM, Sun JV, Tsay YG, Rock HS, Nicolson R. IgE FAST inhibition. A rapid technique for the standardization of pollen allergen extract potency. Ann Allergy 1986;56:222 225
  • 16
    Gleich GJ, Zimmermann EM, Henderson LL, Yunginger JW. Effect of immunotherapy on IgE and IgG antibodies to ragweed antigens. A six-year prospective study. J Allergy Clin Immunol 1982;70:261 271
  • 17
    Witteman AM, Stapel SO, Sjamsoedin DH, Jansen HM, Aalberse RC, Van Der Zee JS. Fel d 1 specific IgG antibodies induced by natural exposure have blocking activity in skin test. Int Arch Allergy Immunol 1996;109:369 375
  • 18
    Varney VA, Hamid QA, Gaga M, Durham RS. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late phase cutaneous response. J Clin Invest 1993;92:644 651